![Medicine / Research / Protease inhibitors / Design of experiments / Evaluation methods / Boceprevir / Clinical trial / Telaprevir / Hepatitis C virus / Science / Clinical research / Pharmacology Medicine / Research / Protease inhibitors / Design of experiments / Evaluation methods / Boceprevir / Clinical trial / Telaprevir / Hepatitis C virus / Science / Clinical research / Pharmacology](https://www.pdfsearch.io/img/48f7c5f619dc61517853d3571af72f11.jpg)
| Open Document File Size: 424,70 KBShare Result on Facebook
Company SVR12 Subgroup / Janssen Research and Development LLC / ITT / / Continent North America / Europe / South America / / Country United States / Australia / New Zealand / / Event FDA Phase / / IndustryTerm HCV treatment / / MedicalCondition disease / chronic HCV / cirrhosis / compensated liver disease / hepatitis C / HCV / Metavir Fibrosis / infection / chronic HCV infection / treatment-naïve CHC / chronic hepatitis C / fibrosis / HCV RNA / HCV genotype / / Organization Antiviral Products Advisory Committee / FOOD AND DRUG ADMINISTRATION / Review Division / ADVISORY COMMITTEE / FDA ANTIVIRAL DRUGS ADVISORY COMMITTEE / / Product GT1 / ribavirin / peginterferon / TMC48PR48 / Q80K / SVR24 / C216 / TMC435-TiDP16 / US / C208 / C206 / Victrelis® / SVR12 / C205 / SVR72 / / Region Asia-pacific / / Technology alpha / genotype / /
SocialTag |